These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 27133692
1. Dual-phase (18)F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan. Tong AK, Zhang ZX, Zaheer S, Yan XS. Clin Imaging; 2016; 40(3):486-91. PubMed ID: 27133692 [Abstract] [Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [Abstract] [Full Text] [Related]
3. Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography. Simone G, Di Pierro GB, Papalia R, Sciuto R, Rea S, Ferriero M, Guaglianone S, Maini CL, Gallucci M. World J Urol; 2015 Oct; 33(10):1511-8. PubMed ID: 25577130 [Abstract] [Full Text] [Related]
4. Role of PET-CT with 18F-fluorocholine in biochemical recurrence after treatment of prostate cancer with curative intent. Puche-Sanz I, Triviño-Ibáñez E, Vázquez-Alonso F, Llamas-Elvira JM, Cózar-Olmo JM, Rodríguez-Fernández A. Actas Urol Esp; 2017 Sep; 41(7):437-444. PubMed ID: 28389027 [Abstract] [Full Text] [Related]
5. 18F-Choline Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for the Detection of Early Local Recurrence of Prostate Cancer Initially Treated by Radiation Therapy: Comparison With Systematic 3-Dimensional Transperineal Mapping Biopsy. Kanoun S, Walker P, Vrigneaud JM, Depardon E, Barbier V, Humbert O, Moulin M, Créhange G, Cormier L, Loffroy R, Brunotte F, Cochet A. Int J Radiat Oncol Biol Phys; 2017 Apr 01; 97(5):986-994. PubMed ID: 28333020 [Abstract] [Full Text] [Related]
6. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study. Rodado-Marina S, Coronado-Poggio M, García-Vicente AM, García-Garzón JR, Alonso-Farto JC, de la Jara AC, Maldonado-Suárez A, Rodríguez-Fernández A. BJU Int; 2015 Jun 01; 115(6):874-83. PubMed ID: 25307619 [Abstract] [Full Text] [Related]
10. Oligometastatic recurrent prostate cancer detects by fluorine-18-choline positron emission tomography/computed tomography in patients with prostate-specific antigen levels of up to 5 ng/ml. Evangelista L, Cuppari L, Guttilla A, Gardi M, Agostini A, Ruggera L, Basso U, Saladini G. Nucl Med Commun; 2018 Mar 01; 39(3):260-267. PubMed ID: 29381584 [Abstract] [Full Text] [Related]
11. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics. Beheshti M, Haim S, Zakavi R, Steinmair M, Waldenberger P, Kunit T, Nader M, Langsteger W, Loidl W. J Nucl Med; 2013 Jun 01; 54(6):833-40. PubMed ID: 23559588 [Abstract] [Full Text] [Related]
12. Acquisition with (11)C-choline and (18)F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis. von Eyben FE, Kairemo K. Ann Nucl Med; 2016 Jul 01; 30(6):385-92. PubMed ID: 27173771 [Abstract] [Full Text] [Related]
13. The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer. Evangelista L, Cimitan M, Hodolič M, Baseric T, Fettich J, Borsatti E. Abdom Imaging; 2015 Oct 01; 40(8):3230-7. PubMed ID: 26428685 [Abstract] [Full Text] [Related]
14. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis. Evangelista L, Cimitan M, Zattoni F, Guttilla A, Zattoni F, Saladini G. Scand J Urol; 2015 Oct 01; 49(5):345-53. PubMed ID: 25649494 [Abstract] [Full Text] [Related]
16. First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy. Buchegger F, Garibotto V, Zilli T, Allainmat L, Jorcano S, Vees H, Rager O, Steiner C, Zaidi H, Seimbille Y, Ratib O, Miralbell R. Eur J Nucl Med Mol Imaging; 2014 Jan 01; 41(1):68-78. PubMed ID: 24104592 [Abstract] [Full Text] [Related]
17. [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence]. Poncet D, Arnoux V, Descotes JL, Rambeaud JJ, Verry C, Terrier N, Boillot B, Dubreuil J, Lanchon C, Carnicelli D, Fiard G, Long JA. Prog Urol; 2015 May 01; 25(6):325-30. PubMed ID: 25748788 [Abstract] [Full Text] [Related]
20. Usefulness of 18F-fluorocoline PET/CT in prostate cancer patients with biochemical recurrence: Influence of PSA kinetics and hormone therapy. Triviño-Ibáñez EM, Puche-Sanz I, Gómez-Río M, Cózar Olmo JM, Llamas-Elvira JM, Rodríguez-Fernández A. Med Clin (Barc); 2019 Jul 19; 153(2):56-62. PubMed ID: 30660434 [Abstract] [Full Text] [Related] Page: [Next] [New Search]